<?xml version="1.0" encoding="UTF-8"?>
<p id="para0025">The role of postconvalescent plasma for prevention and therapy remains undefined, and this should be used only in clinical trials. Many trials are currently running or in evaluation. The standardization of antibody concentration remains an important issue.</p>
